NEWFUND

Thesis

Newfund is an early-stage venture capital firm founded in 2008, operating with an entrepreneurial ethos and a dual presence in Paris, France, and Silicon Valley, USA. The firm's core philosophy is to support founders with global ambition and significant personal investment, mirroring Newfund's own commitment as major LPs in their funds. They primarily focus on pre-seed and seed-stage startups, often providing the initial institutional capital. Newfund invests in companies with an international mindset and a vision for global impact, showing particular interest in fintech, healthcare (including precision medicine, personalized treatment, and brain technologies), foodtech, energy transition, and cybersecurity, though they are industry-agnostic. Their strategy involves writing initial checks ranging from $250,000 to $2 million, with a dedicated fund for the Nouvelle-Aquitaine region starting at $100,000. They actively participate in follow-on rounds and emphasize a fast-paced investment process, aiming for term sheets within three weeks. Newfund invests in startups located in France and the United States, with interests extending to companies in Africa and the Middle East. They manage $400 million in AUM, with their latest generalist fund closing in 2024 at €70 million and a specialized €60 million fund for brain technologies. Their LPs are primarily entrepreneurs and family offices.

Related lists

• Pre-seed AI investors
• Pre-seed Fintech investors
• Pre-seed Security investors